A homozygous loss-of-function mutation in inositol monophosphatase 1 (IMPA1) causes severe intellectual disability.

Autor: Figueiredo T; Northeast Biotechnology Network (RENORBIO), Federal University of Paraiba (UFPB), Joao Pessoa, Brazil.; Department of Biology, Paraiba State University (UEPB), Campina Grande, Brazil.; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, Biosciences Institute, University of Sao Paulo (USP), Sao Paulo, Brazil., Melo US; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, Biosciences Institute, University of Sao Paulo (USP), Sao Paulo, Brazil., Pessoa AL; Department of Neurology, School of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil.; School of Medicine, Fortaleza University (UNIFOR), Fortaleza, Brazil., Nobrega PR; Department of Neurology, School of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil., Kitajima JP; Mendelics Genomic Analysis, Sao Paulo, Brazil., Rusch H; Laboratory of Genetic Metabolic Diseases, Department of Clinical Chemistry, University of Amsterdam, Academic Medical Center (AMC), Amsterdam, The Netherlands., Vaz F; Laboratory of Genetic Metabolic Diseases, Department of Clinical Chemistry, University of Amsterdam, Academic Medical Center (AMC), Amsterdam, The Netherlands., Lucato LT; Institute of Radiology, School of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil., Zatz M; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, Biosciences Institute, University of Sao Paulo (USP), Sao Paulo, Brazil., Kok F; Department of Genetics and Evolutionary Biology, Human Genome and Stem Cell Research Center, Biosciences Institute, University of Sao Paulo (USP), Sao Paulo, Brazil.; Department of Neurology, School of Medicine, University of Sao Paulo (USP), Sao Paulo, Brazil.; Mendelics Genomic Analysis, Sao Paulo, Brazil., Santos S; Northeast Biotechnology Network (RENORBIO), Federal University of Paraiba (UFPB), Joao Pessoa, Brazil.; Department of Biology, Paraiba State University (UEPB), Campina Grande, Brazil.
Jazyk: angličtina
Zdroj: Molecular psychiatry [Mol Psychiatry] 2016 Aug; Vol. 21 (8), pp. 1125-9. Date of Electronic Publication: 2015 Sep 29.
DOI: 10.1038/mp.2015.150
Abstrakt: The genetic basis of intellectual disability (ID) is extremely heterogeneous and relatively little is known about the role of autosomal recessive traits. In a field study performed in a highly inbred area of Northeastern Brazil, we identified and investigated a large consanguineous family with nine adult members affected by severe ID associated with disruptive behavior. The Genome-Wide Human SNP Array 6.0 microarray was used to determine regions of homozygosity by descent from three affected and one normal family member. Whole-exome sequencing (WES) was performed in one affected patient using the Nextera Rapid-Capture Exome kit and Illumina HiSeq2500 system to identify the causative mutation. Potentially deleterious variants detected in regions of homozygosity by descent and not present in either 59 723 unrelated individuals from the Exome Aggregation Consortium (Browser) or 1484 Brazilians were subject to further scrutiny and segregation analysis by Sanger sequencing. Homozygosity-by-descent analysis disclosed a 20.7-Mb candidate region at 8q12.3-q21.2 (lod score: 3.11). WES identified a homozygous deleterious variant in inositol monophosphatase 1 (IMPA1) (NM_005536), consisting of a 5-bp duplication (c.489_493dupGGGCT; chr8: 82,583,247; GRCh37/hg19) leading to a frameshift and a premature stop codon (p.Ser165Trpfs*10) that cosegregated with the disease in 26 genotyped family members. The IMPA1 gene product is responsible for the final step of biotransformation of inositol triphosphate and diacylglycerol, two second messengers. Despite its many physiological functions, no clinical phenotype has been assigned to this gene dysfunction to date. Additionally, IMPA1 is the main target of lithium, a drug that is at the forefront of treatment for bipolar disorder.
Databáze: MEDLINE